Indies Pharma Jamaica Limited (JMSE:INDIES)
Jamaica
· Delayed Price · Currency is JMD 2.820
+0.310 (12.35%)
At close: Apr 28, 2026
Indies Pharma Jamaica Ratios and Metrics
Market cap in millions JMD. Fiscal year is November - October.
Millions JMD. Fiscal year is Nov - Oct.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 27, 2026 | Oct '25 Oct 31, 2025 | Oct '24 Oct 31, 2024 | Oct '23 Oct 31, 2023 | Oct '22 Oct 31, 2022 | Oct '21 Oct 31, 2021 | 2020 - 2016 |
| Market Capitalization | 3,758 | 3,784 | 4,224 | 4,184 | 4,184 | 4,531 | Upgrade
|
| Market Cap Growth | -9.90% | -10.41% | 0.95% | - | -7.65% | 25.93% | Upgrade
|
| Enterprise Value | 4,533 | 4,412 | 4,904 | 4,839 | 4,918 | 5,265 | Upgrade
|
| Last Close Price | 2.82 | 2.71 | 2.90 | 2.76 | 2.66 | 2.78 | Upgrade
|
| PE Ratio | 29.35 | 20.88 | 19.10 | 19.64 | 18.95 | 26.99 | Upgrade
|
| PS Ratio | 3.48 | 3.36 | 3.65 | 3.96 | 4.46 | 5.35 | Upgrade
|
| PB Ratio | 2.15 | 2.19 | 3.27 | 3.43 | 3.62 | 4.17 | Upgrade
|
| P/TBV Ratio | 3.06 | 3.06 | 5.08 | 5.38 | 5.38 | 5.89 | Upgrade
|
| P/FCF Ratio | 13.06 | 11.82 | 17.52 | 15.76 | 14.49 | 13.91 | Upgrade
|
| P/OCF Ratio | 11.10 | 10.40 | 16.90 | 14.97 | 13.27 | 12.36 | Upgrade
|
| EV/Sales Ratio | 4.19 | 3.92 | 4.23 | 4.59 | 5.25 | 6.22 | Upgrade
|
| EV/EBITDA Ratio | 15.76 | 15.32 | 16.17 | 16.74 | 16.34 | 22.55 | Upgrade
|
| EV/EBIT Ratio | 20.76 | 16.76 | 17.32 | 17.91 | 17.46 | 24.22 | Upgrade
|
| EV/FCF Ratio | 15.75 | 13.77 | 20.34 | 18.23 | 17.02 | 16.16 | Upgrade
|
| Debt / Equity Ratio | 0.69 | 0.59 | 0.66 | 0.74 | 0.71 | 0.79 | Upgrade
|
| Debt / EBITDA Ratio | 4.19 | 3.08 | 2.48 | 2.73 | 2.41 | 3.15 | Upgrade
|
| Debt / FCF Ratio | 4.19 | 3.17 | 3.55 | 3.40 | 2.82 | 2.63 | Upgrade
|
| Net Debt / Equity Ratio | 0.44 | 0.34 | 0.49 | 0.53 | 0.50 | 0.61 | Upgrade
|
| Net Debt / EBITDA Ratio | 3.14 | 2.06 | 2.09 | 2.23 | 1.93 | 2.86 | Upgrade
|
| Net Debt / FCF Ratio | 2.69 | 1.85 | 2.63 | 2.43 | 2.01 | 2.05 | Upgrade
|
| Asset Turnover | 0.39 | 0.42 | 0.51 | 0.49 | 0.46 | 0.46 | Upgrade
|
| Inventory Turnover | 2.47 | 2.26 | 2.22 | 2.41 | 1.63 | 1.79 | Upgrade
|
| Quick Ratio | 3.02 | 2.91 | 0.45 | 2.92 | 5.70 | 3.19 | Upgrade
|
| Current Ratio | 4.13 | 4.98 | 0.85 | 5.07 | 10.24 | 5.84 | Upgrade
|
| Return on Equity (ROE) | 8.26% | 11.99% | 17.61% | 17.93% | 19.68% | 18.62% | Upgrade
|
| Return on Assets (ROA) | 4.92% | 6.14% | 7.78% | 7.88% | 8.62% | 7.30% | Upgrade
|
| Return on Invested Capital (ROIC) | 8.19% | 11.21% | 13.12% | 14.69% | 16.14% | 14.28% | Upgrade
|
| Return on Capital Employed (ROCE) | 7.50% | 9.20% | 20.60% | 12.90% | 14.20% | 11.20% | Upgrade
|
| Earnings Yield | 3.43% | 4.79% | 5.24% | 5.09% | 5.28% | 3.71% | Upgrade
|
| FCF Yield | 7.66% | 8.46% | 5.71% | 6.34% | 6.90% | 7.19% | Upgrade
|
| Dividend Yield | 5.00% | 4.98% | 3.79% | 3.99% | 4.25% | 3.96% | Upgrade
|
| Payout Ratio | 139.61% | 99.23% | 66.27% | 70.86% | 68.20% | 87.32% | Upgrade
|
| Total Shareholder Return | 4.25% | 4.98% | 3.79% | 3.99% | 4.25% | 3.96% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.